ClareNow
Search
ClareNow
Toggle sidebar
Science ↑ Positive

A New Tool To Peer Inside The Cell

Engineered fluorescent nanobodies that work inside living cells can label multiple proteins in different colors at once, revealing real-time cellular activity.

Forbes 2 min read 7/10
A New Tool To Peer Inside The Cell
Key Takeaways
  • Engineered fluorescent nanobodies are derived from llama antibodies and are only 2–3 nanometers in size, far smaller than traditional antibody tags (150 nm).
  • The new nanobodies can label up to four distinct proteins in different fluorescent colors simultaneously inside living cells.
  • They are reversible: a light-sensitive switch allows researchers to turn labeling on and off at will, enabling pulse-chase experiments.
  • The method has already been used to observe signaling proteins during cell division and to track calcium dynamics in neurons.
  • Protocols and DNA sequences are freely available, with a commercial kit expected within two years for broad adoption.
  • The nanobodies operate in the reducing environment of the cytoplasm, a feat previously considered impossible for antibody-derived probes.
  • Researchers demonstrated the tool in cancer cell lines and primary neurons, showing real-time drug-target engagement.
For the first time, scientists can watch multiple proteins interact inside a living cell in real time, thanks to a new class of engineered fluorescent nanobodies. A team of biochemists has developed nanobodies—tiny antibody fragments from llamas—that are stable and functional inside the reducing environment of living cells. These nanobodies can label up to four different proteins simultaneously using distinct fluorescent colors, revealing dynamic molecular events previously invisible. The breakthrough, reported in a recent Forbes article by William Haseltine, overcomes a long-standing hurdle: traditional fluorescent tags are too large or chemically incompatible with the cytoplasm. Earlier nanobody-based probes worked only on cell surfaces or in fixed, dead cells. The new variants are engineered with specific mutations that prevent disulfide bond breakage, allowing them to fold correctly and bind targets inside the cell. The researchers demonstrated the tool by observing the movement of signaling proteins involved in cell division and stress responses. They tracked how proteins changed location and interacted over minutes to hours. The nanobodies are also reversible—they can be switched on and off with light, enabling precise control of labeling. This innovation gives cell biologists a front-row seat to molecular choreography. It is already being used to study how cancer cells resist chemotherapy and how neurons process calcium signals. The technology is open-source; protocols and DNA sequences have been published for labs worldwide. The implications are vast: drug developers can now see exactly where and when a compound hits its target inside a live cell. The method may eventually replace the need for more invasive imaging techniques. Experts caution that the nanobodies may not work for every protein and that brightness can be limiting, but early adopters report high specificity and low background. Next steps include expanding the palette of colors to seven or more and combining the nanobodies with CRISPR to tag endogenous proteins. Within two years, researchers hope to commercialize a kit for routine live-cell imaging. This tool turns a previously opaque cell into a glass house, where every protein's dance becomes visible.

Frequently Asked Questions

Fluorescent nanobodies are tiny antibody fragments from llamas that are engineered to bind to specific proteins inside living cells and glow in different colors under a microscope.

They are designed with mutations that stabilize the protein structure in the reducing environment of the cytoplasm. Once inside, they bind to target proteins and emit fluorescent light, allowing researchers to track movement and interactions in real time.

They show where proteins go, when they interact, and how they change during processes like cell division, stress, or drug treatment. This provides a dynamic view of molecular activity.

Yes, for live-cell imaging. Traditional antibodies are too large and cannot enter living cells easily. Nanobodies are much smaller and can be engineered to work inside the cytoplasm without breaking down.

Yes. They allow researchers to see exactly when and where a drug binds its target inside a living cell, helping to identify off-target effects and improve drug efficacy.

The protocols and DNA sequences have been published open-source, and a commercial kit is expected within two years, making the technology accessible to most molecular biology labs.

Original source

www.forbes.com

Read original

Discussion

Join the discussion

Sign in to post a comment or reply.

No comments yet. Be the first to share your thoughts!

Sign in
Enter your email to receive a one-time sign-in code. No password needed.
Email address